Report Categories
View AllRecent Articles
View All
Orkla India Reports 75 PAT Growth in Q4 FY26 as Digital Commerce Surges
Alphatec ATEC Climbs 255 Resistance at 825 in Focus 20260518
Oxford OXSQG Stock Analysis Flat at 2419 Whats Next 20260515
Scaler Leverages AIFocused Upskilling to Target 25 Online Growth Amid Edtech Industry Consolidation
Asian Stocks Rally on Iran Optimism Nvidia Dips on Sales Forecast
Remote Work Resurgence Poses Challenge for Office REITs Despite Strong Occupancy
NRIX Q1 2026 Earnings Missed EPS Estimates Yet Shares Rise on Pipeline Progress
Cross Country Healthcare CCRN Holds Near Support as Healthcare Staffing Faces Headwinds
Oil Prices Decline as USIran Peace Talks Raise Hopes for Strait of Hormuz Reopening
Social Security Timing Dilemma Claim Now or Wait for Survivor Benefits
Bangladeshs Garment Suppliers Face Intensifying Financial Pressure as Buyer Demands Grow
Indian Equity Markets Wobble as Key Stocks See Mixed Activity
Federal Reserve Minutes Reveal Potential Rate Hikes If Inflation Persists Amid Geopolitical Tensions
China Signals It Is Open to a Deal Keeping TikTok in US
OCFC Q1 2026 Earnings EPS Beats Expectations Amid Modest Share Decline
VRRM Q1 2026 Earnings EPS Beats Estimates Despite Stock Pullback
BLFY Q3 2025 Earnings NarrowerthanExpected Loss Despite EPS Miss
RNGR Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear
TKNO Q1 2026 Earnings EPS Beat Amid Cost Discipline
Bristow Group VTOL Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment
SSD Q1 2026 Earnings EPS Beat Drives Optimism Despite Revenue Uncertainty
Mesabi Trust Q1 2026 Earnings Royalty Income Delivers 021 Per Unit Amid Quiet Quarter
OCS Q1 2026 Earnings WiderthanExpected Loss Despite Pipeline Progress
PubMatic Q1 2026 Earnings EPS Beats Estimates Shares Inch Higher
Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline
External Links
Walmart Stock Dips on Q1 Warning Consumer Pressures and Fuel Costs Weigh on Retail Giant
STSS Q3 2025 Earnings Losses Widen Sharply as Revenue Remains Absent
Atomera Q1 2026 Earnings EPS Narrowly Beats Estimates as Cash Burn Continues
C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage
TKC Q4 2025 Earnings EPS of 440 Amid Modest Stock Decline
Gain Therapeutics Inc GANX Q1 2026 Earnings Narrower Loss Surpasses Estimates Stock Edges Higher
HWM Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Aerospace Demand
ONL Q1 2026 Earnings Significant EPS Miss Amidst Challenging Conditions
AFGE Q1 2026 Earnings EPS Misses Estimates Amid Stable Bond Performance